InvestorsHub Logo
Followers 2
Posts 926
Boards Moderated 0
Alias Born 06/02/2012

Re: None

Friday, 12/31/2021 9:59:51 AM

Friday, December 31, 2021 9:59:51 AM

Post# of 14955
More indirect evidence of a pending libigeland/orpatch - a patent dispute over the use of mass spectroscopy for testing testosterone levels in women. Looks like the patent barriers have been removed, bring on the customers.

Quest vs. LabCorp

JTFM, from what I have read, mass spectroscopy is the most accurate method given the low levels of testosterone in the blood of women. I don't know where that leaves Abbott's Architect testosterone test, but I am sure it will be used as well.

I did my undergraduate research on mass spectroscopy and had my first technical paper published. It must be a sign.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News